CompaniesAralez Pharmaceuticals

Aralez Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

30

By Phase

NA: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

Today

Hover over trial bars to see details

Recent Trials

NCT06509204Collaborator

Real-world Evaluation of JBA GlucoTrojan With Reducose® on Glycemic Response

30 participants

Started: Apr 4, 2023 · Completed: Jun 4, 2023

Funding History (20)

8-K

May 30, 2019

8-K

May 13, 2019

8-K

Mar 7, 2019

8-K

Feb 6, 2019

8-K

Jan 18, 2019

8-K

Dec 12, 2018

8-K

Nov 2, 2018

8-K

Oct 5, 2018

8-K

Oct 1, 2018

8-K

Sep 19, 2018